Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLB1 | P16278 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14032358 | 1.00 | GLB1 (0.31) | GLB1 | |
| SCHEMBL9921598 | 1.00 | GLB1 (0.31) | GLB1 | |
| SCHEMBL8491866 | 0.81 | — | — | |
| SCHEMBL9605762 | 0.80 | — | — | |
| SCHEMBL278784 | 0.80 | — | — | |
| SCHEMBL561105 | 0.80 | — | — | |
| SCHEMBL9606081 | 0.80 | — | — | |
| SCHEMBL11421394 | 0.80 | — | — | |
| SCHEMBL19860431 | 0.80 | — | — | |
| SCHEMBL1461040 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507867-B2 | Bicyclo[2.2.1] heptane derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| CN-111918953-B | Lubricant base oil, lubricant composition containing the same, and continuously variable transmission using the same | 出光兴产株式会社 | 2022-10-04 | — | — | CN | disclosed |
| EP-3778834-A1 | LUBRICATING OIL BASE OIL, LUBRICATING OIL COMPOSITION CONTAINING SAME, AND CONTINUOUSLY VARIABLE TRANSMISSION USING SAID LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20200339570-A1 | BICYCLIC DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2020-10-29 | — | — | US | disclosed |
| US-10669268-B2 | Bicyclic derivatives | HOFFMANN-LA ROCHE INC. (US) | 2020-06-02 | — | — | US | disclosed |
| EP-2900669-B1 | HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES | HOFFMANN LA ROCHE (CH) | 2019-09-04 | — | — | EP | disclosed |
| EP-2597140-B1 | USE OF A LUBRICATING OIL COMPOSITION FOR CONTINUOUSLY VARIABLE TRANSMISSION | IDEMITSU KOSAN CO (JP) | 2019-07-03 | — | — | EP | disclosed |
| EP-0402881-B1 | Process for improving the coefficient of traction. | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-29 | — | — | EP | disclosed |
| WO-1993004070-A1 | SUBSTITUTED ACRYLAMIDO-PENICILLANIC ACID DERIVATIVES | SMITHKLINE BEECHAM, PLC (GB) | 1993-03-04 | — | — | WO | disclosed |
| EP-0508292-A1 | Traction drive fluid, process for producing the same and bicyclo octane compound | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-10-14 | — | — | EP | disclosed |
| US-5126065-A | PROCESS FOR IMPROVING THE COEFFICIENT OF TRACTION AND TRACTION DRIVE FLUID | IDEMITSU KOSAN CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| EP-0421752-A2 | Substituted acrylamido-penicillanic acid derivatives | Beecham Group p.l.c. (GB) | 1991-04-10 | — | — | EP | disclosed |
| EP-0402881-A1 | Process for improving the coefficient of traction. | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10669268-B2 | Bicyclic derivatives | CCNY, BICRA, UQCRB | GLB1 2066/4885 |
| US-20200339570-A1 | BICYCLIC DERIVATIVES | CCNY, BICRA, UQCRB | GLB1 2066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.